Navigation Links
InterMune in Medical News

Former InterMune CEO W. Scott Harkonen Indicted for Wire Fraud and FDA Violations

SAN FRANCISCO, March 18 /PRNewswire-USNewswire/ -- W. Scott Harkonen, M.D., the former CEO of InterMune Inc., was indicted on wire fraud and felony Food, Drug and Cosmetic Act charges for his role in the creation and dissemination of false and misleading information about the efficacy of Inter...

New Report Just Published: World Hepatitis C Virus And Therapeutics Market Report

...d Tripep Release Additional Interim Results for ChronVac-C(R) II-56 intermune Starts Clinical Study of ITMN-191 II-57 Roche and Associates Commence C... and Ortho-Clinical II-66 Peregrine Opens Subsidiary in China II-66 intermune Completes Production Milestone II-66 Arrow Expands Hepatitis C Pipeline...

Important Data Presented on Independent Predictors of Mortality in Patients With Idiopathic Pulmonary Fibrosis

...uch an index." About the CAPACITY Program intermune has reported the results of two concurrent, random...ported in the du Bois presentation at ATS. intermune expects to submit a new drug application (NDA) to ... rash and gastrointestinal symptoms. About intermune ...

InterMune to Present at Cowen Health Care Conference

...er or download any necessary software. About intermune intermune is a biotechnology company focused on the research...novative therapies in pulmonology and hepatology. intermune has a pipeline portfolio addressing idiopathic pul...

InterMune Reports Results from Triple Combination Study of ITMN-191

...Chairman, Chief Executive Officer and President of intermune said, "We are very pleased to report that in this ...All-oral STAT-C study) In November 2008, Roche, intermune and Pharmasset initiated the first all-oral combin...ar. Conference Call and Webcast Details intermune will host a conference call today at 8:30 a.m. EST...

InterMune to Present at Thomas Weisel Partners Healthcare Conference

...wnload any necessary software. About InterMune intermune is a biotechnology company focused on the research...nnovative therapies in pulmonology and hepatology. intermune has a research and development portfolio addressin...et in hepatology. For additional information about intermune and its R&D pipeline, please visit http://www.int...

InterMune to Present at the 2008 Wachovia Healthcare Conference

...wnload any necessary software. About InterMune intermune is a biotechnology company focused on the research...nnovative therapies in pulmonology and hepatology. intermune has a pipeline portfolio addressing idiopathic pul...et in hepatology. For additional information about intermune and its R&D pipeline, please visit http://www.int...

Manufacturer to Pay $20 Million for Improperly Promoting a Sleep Disorder Drug

...l scrutiny recently for their drug marketing practices. In October, intermune of Brisbane agreed to pay $36.9 million to settle federal charges it engage...ting a bone disorder and a condition that makes people prone to infections, intermune was accused of improperly promoting it to treat a fatal lung disease. ...
InterMune in Medical Technology

Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C

PRINCETON, N.J., Nov. 10 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS ), Roche (SWX: ROG) and InterMune, Inc. (Nasdaq: ITMN ) today announced that the first patients have been dosed in an innovative clinical trial in patients chronically infected with the hepatitis C virus (HCV)....

Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS)

...enerally well tolerated in both CAPACITY studies. intermune is preparing a New Drug Application (NDA) expected...To better understand the primary efficacy outcome, intermune conducted an exploratory analysis that interrogate...for the treatment of IPF. Webcast Details intermune will host a teleconference and webcast, with accom...

Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen

...loped by other companies. The collaborations with intermune and Pharmasset position Roche as a leader in devel... for HCV. Dial-In and Webcast Details intermune and Pharmasset will host a live webcast of a discu...INFORM-1 trial. Members of management from Roche, intermune and Pharmasset will also be available to answer qu...

Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C

...els of HCV(<15 IU/ml) after 4 weeks, compared to 60 percent in the standard of care arm. In November 2008, Roche, Pharmasset and intermune initiated the INFORM-1 trial to investigate the combination of R7128 with InterMune's R7227, a protease inhibitor, in HCV patients. This is the first-...

InterMune Reports Presentation of Triple Combination Study of ITMN-191 at European Association for the Study of the Liver (EASL)

...file of ITMN-191 observed will be confirmed." intermune noted that a Phase 2b triple combination trial of ... INFORM-1 Program In November 2008, Roche, intermune and Pharmasset initiated the first all-oral combin...meeting on Saturday, April 25, 2009. About intermune ...

InterMune to Announce Results of Phase 3 CAPACITY Program of Pirfenidone in IPF Tomorrow, February 3

...IPF) prior to market open on Tuesday, February 3. intermune will conduct a conference call and webcast, with a...ntering the conference ID# 84164912. About intermune intermune is a biotechnology company focused on the research...

InterMune to Conduct Conference Call and Webcast to Discuss Results of Triple Combination Study of ITMN-191

...ntering the conference ID# 80676348. About intermune intermune is a biotechnology company focused on the research...et in hepatology. For additional information about intermune and its R&D pipeline, please visit htpp:// www...

InterMune to Report Top-Line Results of Triple Combination Study of ITMN-191 in January 2009

...ng with a total daily dose of 300mg. About intermune intermune is a biotechnology company focused on the research...s in hepatology. For additional information about intermune and its R&D pipeline, please visit http://www...

InterMune Announces Start of 14-Day Triple Combination Study of ITMN-191 in Patients With Chronic Hepatitis C

...ic hepatitis C virus (HCV) genotype 1 infection. intermune also reported that results from the only cohort of... ITMN-191 when given with Pegasys and ribavirin. intermune expects to announce top-line results from the trip...r of this year. Publication Plans for ITMN-191 intermune intends to submit several abstracts regarding ITMN...

InterMune Announces Receipt of Fast Track Designation for Pirfenidone From FDA

...ast and Conference Call on May 20, 5:00 p.m. EDT intermune additionally announced that it will conduct a live...wnload any necessary software. About InterMune intermune is a biotechnology company focused on the research...nnovative therapies in pulmonology and hepatology. intermune has a research and development portfolio addressin...
InterMune in Biological Technology

Evotec Expands Collaboration With InterMune

Fragment-Based Drug Discovery Program Yields Results and Leads to Expansion of Collaboration HAMBURG, Germany and OXFORD, England, March 6 /PRNewswire-FirstCall/ -- Evotec AG (Frankfurt Stock Exchange: EVT) today announced that InterMune, Inc., has signed a second drug...

InterMune to Present at Canaccord Adams Conference

... or download any necessary software. About intermune intermune is a biotechnology company focused on the research...novative therapies in pulmonology and hepatology. intermune has an R&D portfolio addressing idiopathic pul...

InterMune Reports Second Quarter 2009 Financial Results and Business Highlights

...ond quarter and six months ended June 30, 2009. intermune reported a net loss for the second quarter of 2009...eral months have been exceptionally productive for intermune and the coming months promise to be even more so. ...esults for the Three Months Ended June 30, 2009 intermune reported total revenue in the second quarter of 20...

InterMune to Release Second Quarter Financial Results on August 6

...live conference call and webcast will be hosted by intermune at 4:30 p.m. Eastern time that same day. To...ntering the conference ID# 22196018. About intermune intermune is a biotechnology company focused on the research...

InterMune to Present at Goldman Sachs Healthcare Conference

...er or download any necessary software. About intermune intermune is a biotechnology company focused on the research...novative therapies in pulmonology and hepatology. intermune has a pipeline portfolio addressing idiopathic pul...

Results From Phase 3 CAPACITY Program of Pirfenidone in IPF and Study of Predictors of Mortality in IPF to be Presented at ATS

...HE CAPACITY TRIALS) Webcast Details intermune will host a teleconference and webcast on Tuesday,... entering the conference ID# 97738057. About intermune intermune is a biotechnology company focused on the research...

Pharmasset Reports Fiscal Second Quarter 2009 Financial Results

...lion, or $0.57 per share for the quarter ended March 31, 2008. Recent Highlights: On April 25, 2009, Pharmasset, Roche, and intermune reported results from the INFORM-1 trial as an oral late breaker at the European Association for the Study of the Liver (EASL) in Copenhagen, Denmark....

InterMune Reports First Quarter 2009 Financial Results and Business Highlights

...ons for the first quarter ended March 31, 2009. intermune reported a net loss for the first quarter of 2009 ... to sharing those results as they develop." intermune reported total revenue in the first quarter of 200...tions of Actimmune for the treatment of IPF, which intermune does not promote. Research and development ...

INFORM-1 Clinical Trial Amended to Further Explore Promising Direct Antiviral Regimen in HCV Patients

...tract can be viewed at www.easl.ch About intermune intermune is a biotechnology company focused on the research...novative therapies in pulmonology and hepatology. intermune has an R&D portfolio addressing idiopathic pul...

InterMune to Release First Quarter Financial Results on April 30

...live conference call and webcast will be hosted by intermune at 4:30 p.m. Eastern time that same day. To ... entering the conference ID# 95970767. About intermune intermune is a biotechnology company focused on the research...
Other Tags
(Date:8/1/2014)... 1, 2014 (HealthDay News) -- Patients with the progressive, ... (COPD) have a new weapon to battle the disease, ... The agency approved a new treatment, an inhaled ... leading killer of Americans. COPD, which is often linked ... bronchitis and emphysema. Patients with COPD may ...
(Date:8/1/2014)... According to new market research ... North America, Europe, & ROW), by Vehicle Type ... (Gasoline & Diesel), by After-Treatment Device (DPF, DOC, ... Forecasts to 2019", defines and segments the global ... major countries in all the regions, and estimates ...
(Date:8/1/2014)... NY (PRWEB) August 01, 2014 ... industry have benefited from innovative technologies that have ... resemble a patient's tooth color. Moreover, the burgeoning ... due to age-related tooth ailments. Due to long-term ... many elderly individuals have demanded dental fillings, veneers ...
(Date:8/1/2014)... (PRWEB) August 01, 2014 ... Market Outlook to 2020", provides key market ... market. The report provides value, in millions ... average prices (in US dollars) within market ... Ultrasonic Generators and Argon Plasma Coagulation Generators. ...
(Date:8/1/2014)... Kathleen Doheny HealthDay Reporter ... control pills containing high doses of estrogen, along with ... cancer in women under 50, new preliminary research ... lead researcher Elisabeth Beaber, a staff scientist at the ... these formulations increase breast cancer risk while other formulations ...
Breaking Medicine News(10 mins):Health News:FDA Approves New Treatment for People With COPD 2Health News:Automotive Exhaust Systems Market Will Be $33,379.7 Million by 2019 – New Report by MarketsandMarkets 2Health News:Automotive Exhaust Systems Market Will Be $33,379.7 Million by 2019 – New Report by MarketsandMarkets 3Health News:Automotive Exhaust Systems Market Will Be $33,379.7 Million by 2019 – New Report by MarketsandMarkets 4Health News:Cosmetic Dentists in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Cosmetic Dentists in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:United Kingdom Surgical Generators Market Size, Share, Analysis, Trends and Forecasts 2020 2Health News:United Kingdom Surgical Generators Market Size, Share, Analysis, Trends and Forecasts 2020 3Health News:Some Birth Control Pills May Up Breast Cancer Risk 2Health News:Some Birth Control Pills May Up Breast Cancer Risk 3
(Date:8/1/2014)... 10,000 reptile species have been recorded into the ... reptile species and classification, making the reptile species ... world, alongside bird and fish species. , For ... mark the year that reptiles would become the ... include snakes, lizards, turtles, crocodiles, tuataras and amphisbaenians. ...
(Date:8/1/2014)... of the UC Davis Center for Neuroscience and ... Science and Engineering Faculty Fellowship from the U.S. ... will support new work on learning and memory ... , The new project aims to connect neural ... in the cortex and hippocampus, brain regions that ...
(Date:8/1/2014)... of marine mammals have officially named a species ... Sousa sahulensis , according to the Wildlife Conservation ... describing the newly named species is the culmination ... available historical records, physical descriptions, and genetic data ... ranging from the coast of West Africa to ...
Breaking Biology News(10 mins):Reptile Database surpasses 10,000 reptile species 2Reptile Database surpasses 10,000 reptile species 3Scientists name new species of cetacean: The Australian humpback dolphin 2Scientists name new species of cetacean: The Australian humpback dolphin 3
Other Contents